Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project

Clinical Toxicology

Volumn 53, Issue 7, 2015, Pages 609-617

  Bäckberg, Matilda ^a   Beck, Olof ^b   Jönsson, Karl Henrik ^c   Helander, Anders ^b  

^a Swedish Poisons Information Center   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Butyrfentanyl; Butyrylfentanyl; Fentanyl analogue; Internet drugs; Mass spectrometry methods; New psychoactive substances; NPS; Opioid analgesic drug; para Fluorobutyrfentanyl

Indexed keywords

4 FLUOROBUTYRFENTANYL; BUTYRFENTANYL; FENTANYL DERIVATIVE; NALOXONE; OPIATE; UNCLASSIFIED DRUG; FENTANYL; NARCOTIC ANALGESIC AGENT; STREET DRUG;

ADULT; ALKALOSIS; APNEA; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CONTROLLED STUDY; DRUG INTOXICATION; HUMAN; INSOMNIA; INTUBATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLIC ACIDOSIS; OBSERVATIONAL STUDY; RESPIRATION DEPRESSION; RESPIRATORY ARREST; RESUSCITATION; TACHYCARDIA; UNCONSCIOUSNESS; YOUNG ADULT; CHEMICALLY INDUCED; DOSE RESPONSE; EMERGENCY HEALTH SERVICE; INTENSIVE CARE UNIT; PATHOLOGY; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDY; SWEDEN; URINE;

ADULT; ANALGESICS, OPIOID; APNEA; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; EMERGENCY SERVICE, HOSPITAL; FENTANYL; HUMANS; INTENSIVE CARE UNITS; MALE; MASS SPECTROMETRY; NALOXONE; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; STREET DRUGS; SWEDEN; UNCONSCIOUSNESS; YOUNG ADULT;

EID: 84938593651     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2015.1054505     Document Type: Article

References (46)

1. EMCDDA. European Drug Report 2014: Trends and developments 2014. http://www.emcdda.europa.eu/attachements.cfm/att-228272-EN-TDAT14001ENN.pdf.
2. EMCDDA. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015) 2015. http://www.emcdda.europa.eu/attachements.cfm/att-235958-EN-TD0415135ENN.pdf.
3. Helander A, Bäckberg M, Hulten P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int 2014;243:23-29.
4. Helander A, Bäckberg M, Beck O. MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin Toxicol (Phila) 2014;52:901-904.
5. Kronstrand R, Thelander G, Lindstedt D, Roman M, Kugelberg FC. Fatal intoxications associated with the designer opioid AH-7921. J Anal Toxicol 2014;38:599-604.
6. Simonsen KW, Edvardsen HM, Thelander G, Ojanperä I, Thordardottir S, Andersen LV, et al. Fatal poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int 2015;248:172-180.
7. Stogner J M. The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl " disguised " as other opioids. Ann Emerg Med 2014;64:637-639.
8. Janssen PA. A review of the chemical features associated with strong morphine-like activity. Br J Anaesth 1962;34:260-268.
9. Poklis A. Fentanyl: a review for clinical and analytical toxicologists. J Toxicol Clin Toxicol 1995;33:439-447.
10. Lane ME. The transdermal delivery of fentanyl. Eur J Pharm Biopharm 2013;84:449-455.
11. Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf 1998;19:173-189.
12. Henderson GL. Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases. J Forensic Sci 1991;36:422-433.
13. EMCDDA. EMCDDA Trendspotter study on fentanyl in Europe. 2012. Available at: http://www.emcdda.europa.eu/attachements.cfm/att-191974-EN-TD3112230ENN-Fentanyl.pdf.
14. Tuusov J, Vals K, Tonisson M, Riikoja A, Denissov G, Vali M. Fatal poisoning in Estonia 2000-2009. Trends in illegal drug-related deaths. J Forensic Leg Med 2013;20:51-56.
15. Vardanyan RS, Hruby VJ. Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications. Future Med Chem 2014;6:385-412.
16. Henderson GL. Designer drugs: past history and future prospects. J Forensic Sci 1988;33:569-575.
17. Kram TC, Cooper DA, Allen AC. Behind the identification of China White. Anal Chem 1981;53:1379A - 1386A.
18. de Boer D, Goemans WP, Ghezavat VR, van Ooijen RD, Maes RA. Seizure of illicitly produced para-fluorofentanyl: quantitative analysis of the content of capsules and tablets. J Pharm Biomed Anal 2003;31:557-562.
19. Van Bever WF, Niemegeers CJ, Janssen PA. Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-(3-methyl- 1-(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide and N-(3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl)-N-phenylpropanamide. J Med Chem 1974;17:1047-1051.
20. Martin M, Hecker J, Clark R, Frye J, Jehle D, Lucid EJ, Harchelroad F. China White epidemic: an eastern United States emergency department experience. Ann Emerg Med 1991;20:158-164.
21. Centers for Disease Control and Prevention. Acetyl fentanyl overdose fatalities - Rhode Island, March-May 2013. MMWR Morb Mortal Wkly Rep 2013;62:703-704.
22. Ojanperä I, Gergov M, Liiv M, Riikoja A, Vuori E. An epidemic of fatal 3-methylfentanyl poisoning in Estonia. Int J Legal Med 2008;122:395-400.
23. Cole JB, Dunbar JF, McIntire SA, Regelmann WE, Slusher TM. Butyrfentanyl overdose resulting in diffuse alveolar hemorrhage. Pediatrics 2015. doi: 10.1542/peds.2014-2878.
24. Higashikawa Y, Suzuki S. Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol 2008;26:1-5.
25. Helander A, Beck O, Hägerkvist R, Hulten P. Identification of novel psychoactive drug use in Sweden based on laboratory analysis-initial experiences from the STRIDA project. Scand J Clin Lab Invest 2013;73:400-406.
26. Persson HE, Sjöberg GK, Haines JA, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998;36:205-213.
27. Starmark JE, Stålhammar D, Holmgren E, Rosander B. A comparison of the Glasgow Coma Scale and the Reaction Level Scale (RLS85). J Neurosurg 1988;69:699-706.
28. Meyer MR, Dinger J, Schwaninger AE, Wissenbach DK, Zapp J, Fritschi G, Maurer HH. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)). Anal Bioanal Chem 2012;402:1249-1255.
29. Al-Saffar Y, Stephanson NN, Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 2013;930:112-120.
30. Bäckberg M, Lindeman E, Beck O, Helander A. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila) 2015;53:46-53.
31. Johansson M, Fransson D, Rundlöf T, Huynh NH, Arvidsson T. A general analytical platform and strategy in search for illegal drugs. J Pharm Biomed Anal 2014;100:215-229.
32. Garg A, Solas DW, Takahashi LH, Cassella JV. Forced degradation of fentanyl: identification and analysis of impurities and degradants. J Pharm Biomed Anal 2010;53:325-334.
33. McIntyre IM, Anderson DT. Postmortem fentanyl concentrations: a review. J Forensic Res 2012;3:157.
34. Wermeling DP. Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access. Ther Adv Drug Saf 2015;6:20-31.
35. World Health Organization. Community management of opioid overdose 2014. http://apps.who.int/iris/bitstream/10665/137462/1/978924 1548816-eng.pdf?ua=1&ua=1.
36. Flashback.org. Butyr fentanyl. https://www.flashback.org/t1961523. (Last accessed on April, 2015)
37. Drugs-Forum.com. Butyr-fentanyl Drug Info. https://drugs-forum.com/forum/showthread.php?t=183677. (Last accessed on April, 2015)
38. Bluelight.org. The Big and Dandy Fentanyl Analogues Thread-Acetylfentanyl/Butyrfentanyl. http://www.bluelight.org/vb/threads/615138-The-Big-and-Dandy-Fentanyl-Analogues-Thread-Acetylfentanyl-Butyrfentanyl. (Last accessed on April, 2015)
39. Baron M, Elie M, Elie L. An analysis of legal highs: do they contain what it says on the tin? Drug Test Anal 2011;3:576-581.
40. Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, et al. Purchasing 'legal highs' on the Internet-is there consistency in what you get? QJM 2010;103:489-493.
41. Zamengo L, Frison G, Bettin C, Sciarrone R. Understanding the risks associated with the use of new psychoactive substances (NPS): high variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products. Toxicol Lett 2014;229:220-228.
42. EMCDDA. Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs 2003. http://www.emcdda.europa.eu/attachements.cfm/att-33350-EN-Risk5.pdf.
43. Vevelstad M, Oiestad EL, Middelkoop G, Hasvold I, Lilleng P, Delaveris GJ, et al. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. Forensic Sci Int 2012;219:151-157.
44. Bäckberg M, Beck O, Hulten P, Rosengren-Holmberg J, Helander A. Intoxications of the new psychoactive substance 5-(2-aminopropyl) indole (5-IT): a case series from the Swedish STRIDA project. Clin Toxicol (Phila) 2014;52:618-624.
45. Zuba D, Byrska B. Prevalence and co-existence of active components of 'legal highs'. Drug Test Anal 2013;5: 420-429.
46. Gill JR, Lin PT, Nelson L. Reliability of postmortem fentanyl concentrations in determining the cause of death. J Med Toxicol 2013;9:34-41